Cargando…
Epilepsy and COVID-19: Management of Patients and Optimization of Antiepileptic Treatment in the Pandemic
There are as yet no data pointing to any increase in the incidence of the novel coronavirus infection (COVID-19) or a more severe course of illness in patients with epilepsy. However, considering the high prevalence of epilepsy in patients over 60 years of age, the high comorbidity of epilepsy and a...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569090/ https://www.ncbi.nlm.nih.gov/pubmed/34754132 http://dx.doi.org/10.1007/s11055-021-01142-x |